Simplex Trading’s AGF US Market Neutral Anti-Beta Fund BTAL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-100
Closed -$1K 9100
2025
Q2
$1K Hold
100
﹤0.01% 8261
2025
Q1
$2K Hold
100
﹤0.01% 7932
2024
Q4
$1K Sell
100
-100
-50% -$1.92K ﹤0.01% 8160
2024
Q3
$3K Buy
+200
New +$3.98K ﹤0.01% 7811
2024
Q1
Sell
-100
Closed -$1K 8866
2023
Q4
$1K Buy
+100
New +$1.99K ﹤0.01% 8436

Other funds holding BTAL

Simplex Trading's BTAL Position: Q1 2026 in Review

Simplex Trading reduced its AGF US Market Neutral Anti-Beta Fund (BTAL) stake by 51% in Q1 2026, selling an estimated $12.7K and leaving 890 shares worth $12.4K. The position accounts for ﹤0.01% of the portfolio, ranked #7159.

Simplex Trading first reported a position in BTAL in Q4 2023 and has held it in 5 quarters since. The position peaked at $72K in Q3 2025. 87 funds tracked by Wall St. Rank hold BTAL as of Q1 2026.

  • Simplex Trading held 890 shares of AGF US Market Neutral Anti-Beta Fund worth $12.4K as of Q1 2026.
  • Simplex Trading sold 908 AGF US Market Neutral Anti-Beta Fund shares in Q1 2026, an estimated $12.7K.
  • AGF US Market Neutral Anti-Beta Fund made up ﹤0.01% of Simplex Trading's portfolio in Q1 2026, its #7159 holding.
  • Simplex Trading first reported a position in AGF US Market Neutral Anti-Beta Fund in Q4 2023 and has held it in 5 quarters since.
  • Simplex Trading's AGF US Market Neutral Anti-Beta Fund position peaked at $72K in Q3 2025.
  • 87 funds tracked by Wall St. Rank held AGF US Market Neutral Anti-Beta Fund as of Q1 2026.

Based on Simplex Trading's 13F filing for Q1 2026, filed 14 May 2026.